The Alfred
Melbourne, Victoria, 3004, Australia
NCT Number: NCT03095859
This randomized, feasibility trial (n=40) will compare the effects of an intensive, twice daily inpatient physical rehabilitation program against standard care (once daily) following double lung transplantation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Melbourne, Victoria, 3004, Australia
This trial will involve the participation of patients post lung transplantation, in the initial post-operative period. Recruitment will take place as soon as the patient is medically safe and willing to commence physical rehabilitation within the intensive care unit. Current, standard care for inpatient physical rehabilitation post lung transplant involves a once daily session of physiotherapy for the duration of the patient's initial inpatient stay, and consists of early mobility, aerobic exercise, upper and lower limb strengthening and flexibility or core muscle re-training.
This trial aims to assess the feasibility and safety of twice daily physical rehabilitation sessions during the post-operative period following lung transplantation. The content of the additional physical rehabilitation session will not differ from, but will complement current standard care, and will be delivered by a trained research assistant or physiotherapist. To the investigator's knowledge, there is no current evidence to support the dosage and intensity of inpatient physical rehabilitation following lung transplantation, and it is unsatisfactory to use evidence from other patient groups to guide practice in this area.
To assess the feasibility of an intensive, inpatient physical rehabilitation program post lung transplantation, the investigators will collect the following data: Number of patients eligible for study inclusion; number of patients consented; number of additional, intensive physical rehabilitation sessions completed; reasons for non-completion of sessions; and attrition, or patient withdrawal rate. In order to assess the safety of the program, the investigators will also assess for evidence of early, acute rejection of the transplanted lungs based on the routine collection of tissue samples, and adverse events. Adverse events will be defined as any event likely caused by acute physical rehabilitation, including musculoskeletal injury, patient fall and surgical wound breakdown.
These assessments will be complemented by a number of physical and psychological outcome measures and patient statistics, including tests of physical capacity, participation and strength, quality of life, requirements for additional physical rehabilitation and/or hospital readmissions within 10 weeks of study commencement, discharge destination and patient length of stay data. Assessments will be completed within 3 days of first time to mobilize, after three weeks and finally after 10 weeks post-transplant.
The investigators hypothesise that an intensive, physical rehabilitation program will be safe and feasible to implement in the post-operative phase post lung transplantation, and that participants in the intensive rehabilitation group will be more active at 10 days, and at 10 weeks than those receiving standard, post lung transplant physical rehabilitation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Early mobility, aerobic exercise, upper and lower limb strength and flexibility training, trunk mobility and core strengthening, inclusive of respiratory therapy and education.
Time frame: Patient length of stay is typically two to three weeks following lung transplant surgery.
Quantified by number of patients eligible for inclusion; number of patients consented; number of additional, intensive physical rehabilitation sessions completed during the initial, inpatient stay post operatively; reasons for non-completion of sessions; and attrition.
This will be aggregated into an overall percentage of successful delivery of intervention.
Time frame: Patient length of stay is typically two to three weeks following lung transplant surgery.
Evidence of early, acute rejection on bronchoscopic biopsy and adverse events. Adverse events will be defined as any adverse outcome during the study period, including but not limited to events that could be related to acute physical rehabilitation such as musculoskeletal injury, patient fall and surgical wound dehiscence or breakdown.
Time frame: Pre-transplant results if available. Repeated at 3 and 10 weeks.
Distance walked in six minutes.
Time frame: 7 days (5 days of data) at post-operative day 10 and at 10 weeks.
Physical activity levels.
Time frame: Once daily on physical activity monitoring days, from day 10 - 16 post-transplant, repeated for seven days at 10 weeks post-transplant.
0-10 pain score.
Time frame: Baseline (within 3 days from first time to mobilise), 3 weeks and 10 weeks post-transplant.
Health-related quality of life questionnaire.
Time frame: Baseline (within 3 days from first time to mobilise), inpatient discharge (2-3 weeks), one month and three months.
Amount of sit-stands completed over 60 seconds.
Time frame: Baseline (within 3 days from first time to mobilise), 3 weeks and 10 weeks post-transplant.
Hand-held dynamometer.
Time frame: Baseline (within 3 days from first time to mobilise), 3 weeks and 10 weeks post-transplant.
A valid, reliable and responsive scale of physical capacity in the post-operative patient.
Time frame: Until inpatient discharge, estimated between two to three weeks.
Length of intensive care and total inpatient stay.
Time frame: Inpatient discharge (2-3 weeks) to 10 weeks.
Readmission rates to the acute setting for the duration of study follow-up.
Time frame: Inpatient (acute) discharge, estimated between two to three weeks.
Requirement for formal inpatient physical rehabilitation vs home.
Time frame: Baseline to 10 weeks.
Evidence of any form of chronic lung allograft dysfunction / antibody mediated rejection.
Time frame: 10 weeks.
Forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC) and forced expiratory ratio (FER)).
Time frame: Inpatient discharge (2-3 weeks) to 10 weeks.
Post-transplant outpatient physical rehabilitation uptake - sessions completed.
The Alfred
Other
Post-operative, Inpatient Rehabilitation After Lung Transplant Evaluation: A Feasibility Study
Acronym: PIRATE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06089434
Deglutition Disorders, Digestive System Diseases
Los Angeles, California, United States
View Trial DetailsNCT05041426
CMV, Lung Transplant
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT04601818
Lung Transplant, To Compare Lung Transplant Outcomes Between Study Patients and Standard Patients Who Have Already Undergone Lung Transplantation by Conventional Procedures
Gainesville, Florida, United States
View Trial DetailsNCT06268171
Atrophy, Lung Transplant
Suresnes, Hauts de seine, France
View Trial Details